Skip to main content

PHVS · Pharvaris N.V. · Analyst Estimates

Track PHVS — free
$31.40 +0.91 (+2.98%)
Market Cap
$2.25B
Shares
70.20M
Volume · Oct 6 778.69K Avg daily vol (3M) 744.19K

Analyst Estimates

Compare analyst forecasts for Pharvaris N.V. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-06 10:15 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
EUR
Publication date not stated
-3.01
-2.76569
-2.39
—
-2.76269
-2.64662
-2.765
-2.58191
— — — —
EPS
analysts
Publication date not stated
— — —
13
— — — —
9
1
2
0
Revenue
EUR
Publication date not stated
0
0
0
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
10
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
EUR
Publication date not stated
-3.45
-2.7105
-2.11
—
-2.67933
-2.43938
-2.67017
-2.339
— — — —
EPS
analysts
Publication date not stated
— — —
12
— — — —
8
3
3
2
Revenue
EUR
Publication date not stated
3181000
32222960
54385000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
EUR
Publication date not stated
-0.8
-0.71682
-0.645
—
-0.721
-0.6705
-0.71636
-0.6679
— — — —
EPS
analysts
Publication date not stated
— — —
11
— — — —
8
1
3
1
Revenue
EUR
Publication date not stated
0
0
0
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
EUR
Publication date not stated
-0.9
-0.768
-0.66
—
-0.7734
-0.71783
-0.76491
-0.7146
— — — —
EPS
analysts
Publication date not stated
— — —
11
— — — —
8
1
3
0
Revenue
EUR
Publication date not stated
0
0
0
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
9
— — — — — — — —
Key facts CIK 1830487 CUSIP N69605108 13F (30d) 2 filings 2 filers Visit website Investor relations